28 results on '"Towne, Jennifer E."'
Search Results
2. Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation
3. Identification of small-molecule protein–protein interaction inhibitors for NKG2D
4. Supplementary Figure 3 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
5. Supplementary Figure Legends from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
6. Data from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
7. Supplementary Figure 2 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
8. Supplementary Figure 4 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
9. Supplementary Methods, Figure Legends 1-2 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
10. Supplementary Figure 4 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
11. Supplementary Figure 2 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
12. Supplementary Figure 1 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
13. Supplementary Figure 1 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
14. Supplementary Figure 9 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
15. Supplementary Figure 2 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
16. Supplementary Figure 3 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
17. Supplementary Figure 5 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
18. Data from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
19. Supplementary Methods from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
20. Supplementary Figure 5 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
21. Data from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
22. Supplementary Figure 7 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
23. Supplementary Figure 6 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
24. Supplementary Figure 8 from Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
25. Supplementary Figure 1 from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
26. Supplementary Methods from Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
27. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions
28. Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.